Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Preladenant (Primary) ; Carbidopa; Levodopa
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 15 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Dec 2009 Planned end date changed from 1 Dec 2009 to 1 May 2010 as reported by ClinicalTrials.gov.
- 21 Aug 2009 Additional locations identified as reported by ClinicalTrials.gov.